Thyroid hormone inhibits slow skeletal TnI expression in cardiac TnI-null myocardial cells

Beth Riedel1, Yuanyuan Jia, Jianfeng Du

  • 1Department of Biomedical Science and Center for Molecular Biology and Biotechnology, Florida Atlantic University, 777 Glades Road, Boca Raton, FL 33431, USA.

Tissue & Cell
|February 8, 2005
PubMed

Insights

Cardiac troponin I (cTnI) deficiency causes heart failure. In knockout mice, the fetal TnI isoform (ssTnI) declines without compensation, but thyroid hormone accelerates this decline in cultured cells.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Developmental Biology

Background:

  • Cardiac troponin I (cTnI) is crucial for heart function; its absence leads to acute heart failure and diastolic dysfunction.
  • Two main cardiac TnI isoforms, fetal (ssTnI) and adult (cTnI), are developmentally regulated.
  • Previous research indicated thyroid hormone influences ssTnI gene expression in vivo.

Purpose of the Study:

  • To investigate ssTnI gene expression patterns in cultured cardiac myocytes from wild type and cTnI null mice.
  • To determine if ssTnI compensates for cTnI absence during development in vitro.
  • To examine the effect of thyroid hormone (T3) on ssTnI expression in cultured cTnI null cardiac myocytes.

Main Methods:

  • Primary culture of neonatal cardiac myocytes from wild type and cTnI null mouse hearts.
  • Western blotting assays to quantify TnI isoform levels.
  • Treatment of cTnI null myocytes with thyroid hormone T3 (20 ng/ml).

Main Results:

  • Wild type cardiac myocytes exhibited a TnI isoform switch, mirroring in vivo patterns.
  • In cTnI null myocytes, ssTnI concentration declined steadily from day 1 to 7, without compensatory upregulation.
  • Thyroid hormone T3 accelerated the decline of ssTnI in cTnI null myocytes, differing from in vivo findings.

Conclusions:

  • Cardiac myocyte culture reveals no ssTnI compensation for cTnI absence, contrasting with whole-heart observations.
  • Thyroid hormone alters ssTnI gene expression timing in cultured cardiac myocytes.
  • Cardiac myocyte-intrinsic programmed events, alongside hormonal factors, regulate TnI gene expression.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...